Correspondence 0001493152-23-024051 from ZyVersa Therapeutics, Inc. (ZVSA)
ZyVersa Therapeutics, Inc.
Date: July 7, 2023 · CIK: 0001859007 · Accession: 0001493152-23-024051
AI Filing Summary & Sentiment
Show Raw Text
CORRESP
1
filename1.htm
A.G.P./ALLIANCE
GLOBAL PARTNERS
590
Madison Avenue 28th Floor New York,
New
York 10022
July
7, 2023
VIA
EDGAR
Securities
and Exchange Commission
100 F Street, N.E.
Division
of Corporation Finance
Washington,
D.C. 20549
Re:
ZyVersa Therapeutics, Inc. (the “Company”)
Registration Statement on Form S-1
File No. 333- 272657 (the “Registration Statement”)
Ladies
and Gentlemen:
In
accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, (the “Act”),
A.G.P./Alliance Global Partners, as the sole placement agent, hereby joins the Company’s request for acceleration of the above-referenced
Registration Statement, requesting effectiveness for 5:00 p.m., Eastern Time on July 10, 2023, or as soon thereafter as practicable.
The
undersigned, as the sole placement agent, represents that it has and will comply with the requirements of Rule 15c2-8 under the Securities
Exchange Act of 1934, as amended.
Please
contact Katherine J. Blair of Manatt, Phelps & Phillips, LLP, counsel of the placement agent, at (310) 312-4252 to provide notice
of effectiveness, or if you have any questions or concerns regarding the foregoing. We appreciate your assistance in this matter.
[Signature
page follows]
Very
truly yours,
A.G.P./ALLIANCE
GLOBAL PARTNERS
By:
/s/
Thomas Higgins
Name:
Thomas
Higgins
Title:
Managing
Director